We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Bradley Pharmaceuticals Derivative Action Dismissed

Law360 (November 8, 2006, 12:00 AM EST) -- A state judge has dismissed a pending shareholder derivative action brought against former officers and directors of Bradley Pharmaceuticals Inc. that claimed they breached their fiduciary duties to the company by issuing false financial statements.

The lawsuit was a consolidation of two separate derivative actions alleging abuse of control, gross mismanagement, waste of corporate assets and unjust enrichment, according to court documents.

“This decision by the court is important to our company and our stockholders and supports our position that the plaintiffs’ complaint was unwarranted,” said...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.